Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Glucose meter Stories

2012-12-18 04:20:49

ESPOO, Finland, December 18, 2012 /PRNewswire/ -- Mendor, the Finnish diabetes technology company, continues rapid growth and is happy to announce yet another international partnership. Mendor has signed a distribution agreement with the Swedish affiliate of a major pharmaceutical company, A.Menarini Diagnostics. A. Menarini Diagnostics Sverige will continue the work Mendor started earlier in 2012 in Sweden, in the Vastra Gotaland Region, to make the all-in-one glucose meter...

2012-12-17 05:01:44

According to a new market report published by Transparency Market Research “Global Diabetes Devices Market and Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share and Forecast, 2011 — 2018,” the global diabetes devices and drugs market was worth USD 50.8 billion in 2011 and is expected to reach USD 98.4 billion in 2018, growing at a CAGR of 9.9% from 2011 to 2018. Browse the full report at...

2012-12-11 16:24:52

WORCESTER, Mass., Dec. 11, 2012 /PRNewswire/ -- Grove Instruments Inc., a medical device company based in Worcester, MA, developing the world's first noninvasive glucometer today announced that The Company's first tranche of Series B-1 Preferred Stock was oversubscribed and has closed. The first tranche was set at $3 M in new funds. "This closing enables the company to covert long-term debt notes into equity and greatly strengthens our balance sheet," explained Arthur Combs,...

2012-11-29 08:29:29

WESTLAKE VILLAGE, Calif., Nov. 29, 2012 /PRNewswire/ --While satisfaction with blood glucose meters is high among users, perceived accurate readings and an easy-to-use navigation interface differentiate the highest performers from other meters, according to the J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction Study(SM) released today. (Logo: http://photos.prnewswire.com/prnh/20050527/LAF028LOGO-a) This inaugural study examines satisfaction among meter users who currently...

2012-11-28 08:29:06

ABINGDON, England, November 28, 2012 /PRNewswire/ -- GlySure Limited, developer of in-hospital continuous blood glucose monitoring systems, has completed the second close of its Series C financing round for a total of $13.6 million. GlySure will use this funding to complete clinical trials in support of U.S. and European regulatory clearance. Series C investors included Amadeus Capital Partners, Chester Investments, Delta Partners, Morningside Ventures and Frank Bonsal,...

2012-10-01 06:27:18

INDIANAPOLIS, Oct. 1, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK Combo system for insulin pump therapy is now available in the United States. This market launch follows clearance from the U.S. Food and Drug Administration (FDA) for the ACCU-CHEK Combo system in July 2012. People with diabetes who are interested in learning more about the system should contact Roche Insulin Delivery Services at 1-866-382-2355. (Photo:...

2012-09-26 02:25:45

ALBANY, New York, September 26, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Global Diabetes Devices Market and Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share and Forecast, 2011 - 2018 [http://www.transparencymarketresearch.com/diabetes-devices-market.html ]," the global diabetes devices and drugs market was worth USD 50.8 billion in 2011 and is expected to...

2012-09-21 02:22:39

PITTSBURGH, Sept. 21, 2012 /PRNewswire/ -- Highmark Inc. and Healthrageous, Inc., a digital health management company, announced today they are evaluating a lifestyle behavior modification program to improve the health status of people with Type 2 diabetes. The goal of the program is to use technology in a way that makes the personalized journey of self-managing diabetes easier and more effective. Healthrageous' digital diabetes program takes into account an individual's needs and...

2012-08-22 06:24:36

SALEM, N.H., Aug. 22, 2012 /PRNewswire/ -- AgaMatrix, Inc. today announced the election of Jeffrey B. Kindler to the company's Board of Directors. Mr. Kindler, 56, was previously Chairman and CEO of Pfizer Inc. He joined Pfizer in January 2002 as Executive Vice-President and General Counsel. Before joining Pfizer, Mr. Kindler was an executive at McDonald's Corporation, where he served as President of Partner Brands and as Executive Vice President and General Counsel. Prior to that, he was...

2012-08-13 10:25:28

NEW YORK, Aug. 13, 2012 /PRNewswire/ -- Philosys announced today that it has received the CE Mark for the Gmate® SMART Blood Glucose Monitoring System. According to Jonathan Johnson, Director of Regulatory Affairs, "CE designation will allow Philosys to market the Gmate® SMART within the European Union,(EU), consisting of the 27 EU Member States. Moreover, the CE mark signifies that the product has been assessed before being placed on the market and meets European Union...